Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

RITUXAN HYCELA approved by FDA for subcutaneous injection in certain blood cancers

biospectrumasiaJune 26, 2017

Tag: Rituxan Hycela , FDA

PharmaSources Customer Service